Pharmacogenomics and COVID-19: clinical implications of human genome interactions with repurposed drugs

OA Badary - The pharmacogenomics journal, 2021 - nature.com
The outbreak of Coronavirus disease 2019 (COVID-19) has evolved into an emergent global
pandemic. Many drugs without established efficacy are being used to treat COVID-19 …

PharmGKB summary: very important pharmacogene information for UGT1A1

JM Barbarino, CE Haidar, TE Klein… - Pharmacogenetics and …, 2014 - journals.lww.com
The uridine diphosphate glucuronosyltransferase (UGT) enzymes are a superfamily of
enzymes responsible for the glucuronidation of target substrates. The transfer of glucuronic …

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing

RS Gammal, MH Court, CE Haidar… - Clinical …, 2016 - Wiley Online Library
The antiretroviral protease inhibitor atazanavir inhibits hepatic uridine diphosphate
glucuronosyltransferase (UGT) 1A1, thereby preventing the glucuronidation and elimination …

[图书][B] Human drug metabolism

MD Coleman - 2020 - books.google.com
Provides a timely update to a key textbook on human drug metabolism The third edition of
this comprehensive book covers basic concepts of teaching drug metabolism, starting from …

Will the use of pharmacogenetics improve treatment efficiency in COVID-19?

B Franczyk, J Rysz, J Miłoński, T Konecki… - Pharmaceuticals, 2022 - mdpi.com
The COVID-19 pandemic is associated with a global health crisis and the greatest challenge
for scientists and doctors. The virus causes severe acute respiratory syndrome with an …

Pharmacogenomics research and clinical implementation in Brazil

F Rodrigues‐Soares… - Basic & Clinical …, 2019 - Wiley Online Library
We searched PubMed entries and the Lattes database of Brazilian Pharmacogenetics
Network investigators, for pharmacogenetic/genomic (PGx) studies in the Brazilian …

Polymorphisms associated with renal adverse effects of antiretroviral therapy in a Southern Brazilian HIV cohort

IM da Rocha, AS Gasparotto… - Pharmacogenetics …, 2015 - journals.lww.com
Objective This study evaluated the impact of seven single nucleotide polymorphisms in five
candidate genes (ABCB1, ABCC2, ABCC4, SLC22A6, and SLC22A11) in relation to …

The changing face of human immunodeficiency virus-mediated kidney disease

K Sury, MA Perazella - Advances in Chronic Kidney Disease, 2019 - Elsevier
In nearly 40 years since human immunodeficiency virus (HIV) first emerged, much has
changed. Our understanding of the pathogenesis of HIV infection and its effect on the cells …

UGT1A1 Gene Polymorphism Contributes as a Risk Factor for Lung Cancer: A Pilot Study with Patients from the Amazon

EEB Pereira, LPC Leitão, RB Andrade, AAC Modesto… - Genes, 2022 - mdpi.com
Lung cancer is one of the most frequent neoplasms in the world. Because it is a complex
disease, its formation occurs in several stages, stemming from interactions between …

Pharmacogenetic considerations in the treatment of HIV

VS Mattevi, CFS Tagliari - Pharmacogenomics, 2017 - Taylor & Francis
After the introduction of highly active antiretroviral therapy in the 1990s, the perception of the
diagnosis of HIV infection gradually shifted from a 'death sentence'to a chronic disease …